- AMERICAN PSYCHIATRIC ASSOCIATION (1994). Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC: American Psychiatric Press.
- BHUGRA, D. & BHUI, K.S. (1999). Psychopharmacology and ethnic minorities. Advances in Psychiatric Treatment, 5, 89-95.
- BILLS, L.J. & KREISLER, K. (1993). Treatment of flashbacks with naltrexone. American Journal of Psychiatry, 150, 1430.
- BLEICH, A., SIEGEL, B., GARB, R. & LERER, B. (1986). Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment. British Journal of Psychiatry, 149, 365-369.
- BRADY, K., PEARLSTEIN, T., ASNIS, G.M., BAKER, D., et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomised controlled trial. Journal of American Medical Association, 283, 1837-1844.
- BRAUN, P., GREENBERG, D., DASBERG, H. & LERER, B. (1990). Core symptoms of post traumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry, 51, 236-238.
- BROPHY, M.H. (1991). Cyproheptadine for combat nightmares in post traumatic stress disorder and dream anxiety disorder. Military Medicine, 156, 100-101.
- CHARNEY, D.S., DEUTCH, A.Y., KRYSTAL, J.H., SOUTHWICK, S.M., et al. (1993). Psychobiological mechanisms of post traumatic stress disorder. Archives of General Psychiatry, 50, 295-305.
- CONNOR, K.M. & DAVIDSON, J.R.T. (1998). The role of serotonin in posttraumatic stress disorder. Neurobiology and Pharmacotherapy. CNS Spectrums, 3, 43-51.
- CONNOR, K.M., SUTHERLAND, S.M., TUPLER, L.A., MALIK, M., et al. (1999). Fluoxetine in post traumatic stress disorder. British Journal of Psychiatry, 175, 17-22.
- COOK, M.D. & CONNER, J. (1995). Retrospective review of hypnotic use in combination with fluoxetine or sertraline. Clinical Drug Investigation, 9, 212-216.
- DAVIDSON, J. & SMITH, R. (1990). Traumatic experiences in psychiatric outpatients. Journal of Traumatic Stress, 3, 459-475.
- DAVIDSON, J.R.T., MALIK, M.L. & SUTHERLAND, S.N. (1997a). Response characteristics to antidepressants and placebo in post traumatic stress disorder. International Clinical Psychopharmacology, 12, 291-296.
- DAVIDSON, J.R.T., WEISLER, R.H., MALIK, M.L. & CONNER, M.K. (1998). Treatment of post traumatic stress disorder with nefazodone. International Clinical Psychopharmacology , 13, 111-113.
- DAVIDSON, J.R.T., KUDLER, H.S., SMITH, R.D., MAHOMEY, S.L., et al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.
- DAVIDSON, J., LANDBURG, P.D., PEARLSTEIN, T., WEISLER, R., et al. (1997b). Double blind comparison of sertraline and placebo in patients with posttraumatic stress disorder. Abstracts of the American College of Neuropsychopharmacology 36th Annual Meeting, San Juan, Puerto Rico.
- DILLARD, K.M., BENDFELDT, F. & JERNIGAN, P. (1993). Use of thioridazine in post traumatic stress disorder. Southern Medical Journal, 86, 1276-1278.
- FESLER, F.A. (1991). Valproate in combat related post traumatic stress disorder. Journal of Clinical Psychiatry, 52, 361-364.
- FITCHNER, C.G. & CRAYTON, J.W. (1994). Buspirone in combat related post traumatic stress disorder. Journal of Clinical Psychiatry, 55(Suppl. 8), 66-72.
- FOA, E.B., DAVIDSON, J.R.T. & FRANCES, A. (1999). The Expert Consensus Guideline Series. Treatment of posttraumatic stress disorder. Journal of Clinical Psychiatry, 60(Suppl. 16), 1-76.
- GARLAND, C. (1993). The lasting trauma of the concentration camps. British Medical Journal, 307, 77-78.
- GELPIN, E., BONNE, O., PERI, T., BRANDES, D., et al. (1996). Treatment of recent trauma survivors with benzodiazepines. A prospective study. Journal of Clinical Psychiatry, 57, 390-394.
- HAMNER, M.B. & FRUEH, B.C. (1998). Response to venlafaxine in a previously antidepressant resistant combat veteran with post traumatic stress disorder. International Clinical Psychopharmacology, 13, 233-234.
- HAMNER, M.B., ULMER, H. & HORNE, D. (1997). Buspirone potentiation of antidepressants in the treatment of post traumatic stress disorder. Depression and Anxiety, 5, 137-139.
- HERTZBERG, M.A., FELDMAN, M.E., BECKHAM, J.C. & DAVIDSON, J.R.T. (1996). Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. Journal of Clinical Psychopharmacology, 16, 294-298.
- HERTZBERG, M.A., BUTTERFIELD, M.I., FELDMAN, M.E., BECKHAM, J.C., et al. (1999). A preliminary study of lamotrigine for the treatment of post traumatic stress disorder. Biological Psychiatry, 45, 1226-1229.
- HERTZBERG, M.A., FELDMAN, M.E., BECKHAM, J.C., MOORE, S.D., et al. (1998). Open trial of nefazodone for combat-related posttraumatic stress disorder. Journal of Clinical Psychiatry, 59, 460-464.
- HILDAGO, R., HERTZBERG, M.A., MELLMAN, T.A., et al. (1999). Nefazodone in post traumatic stress disorder. Results from open label trials. International Clinical Psychopharmacology , 14, 61-68.
- HORRIGAN, J.P. (1996). Guanfacine for post traumatic stress disorder nightmares. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 975-976.
- KAPLAN, Z., AMIR, M., SWARTZ, M. & LEVINE, J. (1996). Inositol treatment for post traumatic stress disorder. Anxiety, 2, 51-52.
- KATZ, R.J., LOTT, M.H., ARBUS, P., CROCQ, L., et al. (1994-1995). Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety, 1, 169-174.
- KESSLER, R.C., DAVIS, C.G. & KENDLER, K.S. (1997). Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey. Psychological Medicine, 27, 1101-1119.
- KOSTEN, T.R., FRANK, J.B., DAN, E., MCDOUGLE, C.J., et al. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366-370.
- LEBYA, C.M. & WAMPLER, T.P. (1998). Risperidone in post traumatic stress disorder. Psychiatric Ser vices, 49, 245-246.
- LIPPER, S., DAVIDSON, J.R.T., GRADY, T.A., EDINGER, J.D., et al. (1986). Preliminary study of carbamazepine in post traumatic stress disorder. Psychosomatics, 27, 849-854.
- MARSHALL, R.D., SCHNEIDER, F.R., FALLON, B.A., KNIGHT, C.G., et al. (1998). An open trial of paroxetine in patients with non-combat related, chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology , 18, 10-18.
- MELLMAN, T.A., BYERS, P.M. & AUGENSTEIN, J.S. (1998). Pilot evaluation of hypnotic medication during acute traumatic stress disorder. International Clinical Psychopharmacology , 12, 231-237.
- NAGY, L.M., MORGAN, C.A. 3RD, SOUTHWICK, S.M. & CHARNEY, D.S. (1993). Open prospective trial of fluoxetine for posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 13, 107-113.
- NEAL, L.A., SHEPLAND, W. & FOX, C. (1997). An open trial of moclobemide in the treatment of post traumatic stress disorder. International Clinical Psychopharmacology , 12, 231-237.
- SHAY, J. (1992). Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with post traumatic stress disorder. Journal of Traumatic Stress, 5, 97-101.
- SHESTATSKY, M., GREENBERG, D. & LERER, B. (1988) A controlled trial of phenelzine in post traumatic stress disorder. Psychiatry Research, 24, 149-155.
- SOUTHWICK, S.M., YEHUDA, R., GILLER, E.C. & CHARNEY, D.S. (1994). Use of tricyclics and monoamine oxidase inhibitors in the treatment of post traumatic stress disorder. A quantitative review. In: M.M. MURBURG (Ed.) Catecholamine functions in PTSD: emerging concepts. Washington, DC: American Psychiatric Press.
- STEIN, D.J., ZUNGU-DIRWARYI, N., VAN DER LINDEN, G.J.H. & SEEDAT, S. (2001). Pharmacotherapy for post traumatic stress disorder (Cochrane Review). The Cochrane Library, 1.
- VAN DER KOLK, B.A., DREYFUSS, D., MICHAELS, M., SHERA, D., et al. (1994). Journal of Clinical Psychiatry, 55, 517-522.
- YEHUDA, R. & MCFARLANE, A.C. (1995). Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. American Journal of Psychiatry, 152, 1705-1713.
- ZISOOK, S., CHENTSOVA-DUTTON, Y. & ELLENOR, G. (1999). Nefazodone in patients with treatment refractory post traumatic stress disorder. Presented at the Annual Meeting of the American Psychiatric Association.
Drug treatments in post-traumatic stress disorder
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.